Literature DB >> 11239454

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

I Garcia-Higuera1, T Taniguchi, S Ganesan, M S Meyn, C Timmers, J Hejna, M Grompe, A D D'Andrea.   

Abstract

Fanconi anemia (FA) is a human autosomal recessive cancer susceptibility disorder characterized by cellular sensitivity to mitomycin C and ionizing radiation. Although six FA genes (for subtypes A, C, D2, E, F, and G) have been cloned, their relationship to DNA repair remains unknown. In the current study, we show that a nuclear complex containing the FANCA, FANCC, FANCF, and FANCG proteins is required for the activation of the FANCD2 protein to a monoubiquitinated isoform. In normal (non-FA) cells, FANCD2 is monoubiquitinated in response to DNA damage and is targeted to nuclear foci (dots). Activated FANCD2 protein colocalizes with the breast cancer susceptibility protein, BRCA1, in ionizing radiation-induced foci and in synaptonemal complexes of meiotic chromosomes. The FANCD2 protein, therefore, provides the missing link between the FA protein complex and the cellular BRCA1 repair machinery. Disruption of this pathway results in the cellular and clinical phenotype common to all FA subtypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239454     DOI: 10.1016/s1097-2765(01)00173-3

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  460 in total

1.  hMutSbeta is required for the recognition and uncoupling of psoralen interstrand cross-links in vitro.

Authors:  Nianxiang Zhang; Xiaoyan Lu; Xiaoshan Zhang; Carolyn A Peterson; Randy J Legerski
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.

Authors:  Donna L Mallery; Cassandra J Vandenberg; Kevin Hiom
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

3.  Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.

Authors:  James B Wilson; Eric Blom; Ryan Cunningham; Yuxuan Xiao; Gary M Kupfer; Nigel J Jones
Journal:  Mutat Res       Date:  2010-05-05       Impact factor: 2.433

4.  FANCE: the link between Fanconi anaemia complex assembly and activity.

Authors:  Paul Pace; Mark Johnson; Wu Meng Tan; Georgina Mosedale; Chelvin Sng; Maureen Hoatlin; Johan de Winter; Hans Joenje; Fanni Gergely; K J Patel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

5.  A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein.

Authors:  Nicolas Foray; Didier Marot; Anastasia Gabriel; Voahangy Randrianarison; Antony M Carr; Michel Perricaudet; Alan Ashworth; Penny Jeggo
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

6.  A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome.

Authors:  Amom Ruhikanta Meetei; Salvatore Sechi; Michael Wallisch; Dafeng Yang; Mary K Young; Hans Joenje; Maureen E Hoatlin; Weidong Wang
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

7.  Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway.

Authors:  Andreas Rothfuss; Markus Grompe
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 8.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

9.  Molecular cross-talk among chromosome fragility syndromes.

Authors:  Jordi Surrallés; Stephen P Jackson; Maria Jasin; Michael B Kastan; Stephen C West; Hans Joenje
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

Review 10.  DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.

Authors:  Henning Willers; Liliana Gheorghiu; Qi Liu; Jason A Efstathiou; Lori J Wirth; Mechthild Krause; Cläre von Neubeck
Journal:  Semin Radiat Oncol       Date:  2015-05-14       Impact factor: 5.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.